Memorial Sloan Kettering reports $483M slide in operating income

New York City-based Memorial Sloan Kettering Cancer Center saw a swing from a $235.1 operating gain in 2021 to a 2022 operating loss of $248.1 million.

Advertisement

The $483 million swing was largely due to an 11.6 percent increase in expenses year over year. Total revenue for 2022 was $6.6 billion, up 3.6 percent, according to a financial report from the health system.

Once one-time costs were taken into consideration — reducing leased space and a reduction in the workforce — there were signs of improved operating income in the fourth quarter compared with the previous quarter, which ended Sept. 30, the system said.

“These efforts, including the one-time reorganization costs, will generate future savings and enable MSK to continue to provide excellent patient care,” the report said.

Investment losses in the period totaled $932 million, dragging the overall loss down further. In 2021, there was a $996.7 million gain on such returns.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.